BALYASNY ASSET MANAGEMENT L.P. - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 58 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2021$1,785,000
+83.6%
1,622,510
+634.2%
0.01%
+166.7%
Q4 2017$972,000
-7.0%
221,000
+10.5%
0.00%
-25.0%
Q3 2017$1,045,000200,0000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders